WallStreetZen

NASDAQ: BIOT
Biotech Acquisition Co Stock Ownership

Insider buying vs selling

Have Biotech Acquisition Co insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

BIOT Shareholders

What type of owners hold Biotech Acquisition Co stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Aristeia Capital LLC4.00%1,149,010$11.13MInstitution
H GC Investment Management Inc3.83%1,101,900$10.68MInstitution
Glazer Capital LLC3.67%1,054,547$10.22MInstitution
Bluecrest Capital Management Ltd3.48%1,000,000$9.69MInstitution
Corbin Capital Partners LP3.23%928,124$8.99MInstitution
Citadel Advisors LLC3.11%895,433$8.68MInstitution
Periscope Capital Inc2.58%742,352$7.19MInstitution
Linden Advisors LP2.36%678,849$6.58MInstitution
Polar Asset Management Partners Inc2.09%600,000$5.81MInstitution
Sage Rock Capital Management LP2.00%573,800$5.56MInstitution

1 of 3

Biotech Acquisition Stock Ownership FAQ

Who owns Biotech Acquisition?

Biotech Acquisition (NASDAQ: BIOT) is owned by 64.98% institutional shareholders, 0.00% Biotech Acquisition insiders, and 35.02% retail investors. Aristeia Capital LLC is the largest individual Biotech Acquisition shareholder, owning 1.15M shares representing 4.00% of the company. Aristeia Capital LLC's Biotech Acquisition shares are currently valued at $11.15M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.